We are live on ! Find out more
ARMC

American Research & Management Company Portfolio holdings

AUM $362M
1-Year Est. Return 8.06%
This Fund
S&P 500
This Quarter Est. Return
+5.5%
1 Year Est. Return
-8.06%
3 Year Est. Return
+35.06%
5 Year Est. Return
+60.88%
10 Year Est. Return
AUM
$281M
AUM Growth
-$10.8M
Cap. Flow
-$24.3M
Cap. Flow %
-8.63%
Top 10 Hldgs %
39.74%
Holding
374
New
13
Increased
43
Reduced
92
Closed
35
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYK icon
26
Stryker
SYK
$127B
$3.02M 1.07%
22,930
-440
-2% -$55.6K
DD
27
DELISTED
Du Pont De Nemours E I
DD
$2.79M 0.99%
34,676
-815
-2% -$63.3K
TRP icon
28
TC Energy
TRP
$64.4B
$2.56M 0.91%
55,461
-1,500
-3% -$69.9K
FFIV icon
29
F5
FFIV
$22.3B
$2.56M 0.91%
17,925
-300
-2% -$42.8K
CELG
30
DELISTED
Celgene Corp
CELG
$2.49M 0.89%
20,005
+2,065
+12% +$247K
MRK icon
31
Merck
MRK
$366B
$2.46M 0.88%
40,608
-2,470
-6% -$150K
TFX icon
32
Teleflex
TFX
$5.92B
$2.44M 0.87%
12,584
-100
-0.8% -$18K
BIIB icon
33
Biogen
BIIB
$32.3B
$2.41M 0.86%
8,825
+950
+12% +$269K
TD icon
34
Toronto Dominion Bank
TD
$199B
$2.36M 0.84%
47,036
KO icon
35
Coca-Cola
KO
$386B
$2.02M 0.72%
47,487
BRK.B icon
36
Berkshire Hathaway Class B
BRK.B
$1.08T
$1.96M 0.7%
11,735
-450
-4% -$75.3K
PYPL icon
37
PayPal
PYPL
$45.9B
$1.78M 0.63%
41,480
+15,400
+59% +$644K
MSFT icon
38
Microsoft
MSFT
$3.81T
$1.77M 0.63%
26,909
-848
-3% -$54.3K
T icon
39
AT&T
T
$178B
$1.73M 0.62%
55,211
+625
+1% +$19.7K
SFE
40
DELISTED
Safeguard Scientifics, Inc.
SFE
$1.71M 0.61%
134,516
-3,400
-2% -$42.8K
MKC icon
41
McCormick & Company Non-Voting
MKC
$14.9B
$1.7M 0.6%
34,820
+1,900
+6% +$92K
LQD icon
42
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.9B
$1.58M 0.56%
13,410
-450
-3% -$52.8K
NVDA icon
43
NVIDIA
NVDA
$5.25T
$1.57M 0.56%
578,400
+486,000
+526% +$1.29M
RTX icon
44
RTX Corp
RTX
$285B
$1.48M 0.53%
21,000
+858
+4% +$60.2K
IMO icon
45
Imperial Oil
IMO
$63.1B
$1.47M 0.52%
48,130
+1,970
+4% +$63.7K
HP icon
46
Helmerich & Payne
HP
$4.25B
$1.34M 0.48%
20,210
+9,895
+96% +$704K
FBIN icon
47
Fortune Brands Innovations
FBIN
$5.43B
$1.28M 0.45%
24,551
-1,159
-5% -$56.8K
MAR icon
48
Marriott International
MAR
$91.5B
$1.24M 0.44%
13,149
+284
+2% +$24.7K
PFE icon
49
Pfizer
PFE
$159B
$1.2M 0.43%
37,003
-310
-0.8% -$9.77K
EMLC icon
50
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.79B
$1.16M 0.41%
31,277
+2,427
+8% +$87.8K

Similar funds

American Research & Management Company's Q1 2017 Portfolio in Review

As of Q1 2017, American Research & Management Company held 374 positions worth $281M, down 3.7% from $292M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

American Research & Management Company withdrew a net $24.3M in Q1 2017, closing 35 positions and reducing 92 holdings. Its most notable exit was PrivateBancorp, Inc. Capital Trust IV Trust Preferred, an estimated $5.61M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, American Research & Management Company opened a new position in Bioverativ Inc. Common Stock worth $397K.

  • American Research & Management Company's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 7,291 shares worth $397K.
  • American Research & Management Company added most to NVIDIA in Q1 2017, an estimated $1.29M increase.
  • American Research & Management Company's biggest Q1 2017 reduction was Allied World Assurance Co Hld Lt, cutting an estimated $3.73M.
  • American Research & Management Company fully exited PrivateBancorp, Inc. Capital Trust IV Trust Preferred in Q1 2017, selling an estimated $5.61M.
  • American Research & Management Company's ten largest holdings make up 40% of its $281M portfolio in Q1 2017.
  • American Research & Management Company opened 13 new positions and closed 35 in Q1 2017.
  • American Research & Management Company's portfolio value fell 3.7% quarter-over-quarter to $281M.

Based on American Research & Management Company's 13F filing for Q1 2017, filed 17 Apr 2017.